Welcome to LookChem.com Sign In|Join Free
  • or
2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

108462-95-9

Post Buying Request

108462-95-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

108462-95-9 Usage

Explanation

This is the chemical name of the compound, also known as carprofen.

Explanation

Carprofen belongs to a class of drugs called NSAIDs, which are used to reduce inflammation and pain.

Explanation

Carprofen is mainly used to alleviate pain and inflammation in veterinary patients, specifically dogs and cats.

Explanation

Carprofen works by inhibiting the production of prostaglandins, which are chemicals responsible for causing inflammation and pain.

Explanation

Carprofen is often prescribed to treat various conditions that involve pain and inflammation, such as arthritis, pain after surgery, and injuries to muscles and bones.

Explanation

Carprofen can be administered to animals in different forms, including tablets, chewable tablets for easier consumption, and injections for faster action.

Explanation

Carprofen is usually safe for animals when administered according to a veterinarian's guidance.

Explanation

As with other nonsteroidal anti-inflammatory drugs, carprofen may cause adverse effects, and it is essential to monitor the animal's response to the medication.

Explanation

To ensure the safe and effective use of carprofen, it is crucial to follow a veterinarian's recommendations and monitor the animal's response to the drug.

Classification

Nonsteroidal anti-inflammatory drug (NSAID)

Primary Use

Pain reliever and anti-inflammatory agent for dogs and cats

Mechanism of Action

Inhibition of prostaglandin production

Common Uses

Management of pain and inflammation associated with arthritis, post-operative pain, and musculoskeletal injuries

Available Forms

Tablets, chewable tablets, and injection

Safety and Tolerance

Generally well tolerated when used as directed by a veterinarian

Potential Side Effects

Like other NSAIDs, carprofen can have side effects

Veterinary Supervision

Important to use under veterinary supervision

Check Digit Verification of cas no

The CAS Registry Mumber 108462-95-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,4,6 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 108462-95:
(8*1)+(7*0)+(6*8)+(5*4)+(4*6)+(3*2)+(2*9)+(1*5)=129
129 % 10 = 9
So 108462-95-9 is a valid CAS Registry Number.

108462-95-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(4-chlorobenzoyl)amino]propanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:108462-95-9 SDS

108462-95-9Relevant academic research and scientific papers

Bronsted acid accelerated Pd-catalyzed direct asymmetric allylic alkylation of azlactones with simple allylic alcohols: A practical access to quaternary allylic amino acid derivatives

Zhou, Hui,Yang, Huameng,Liu, Muwen,Xia, Chungu,Jiang, Gaoxi

supporting information, p. 5350 - 5353 (2015/01/09)

A Bronsted acid accelerated Pd-catalyzed asymmetric allylic alkylation of azlactones with simple allylic alcohols under mild reaction conditions has been realized, which provides a direct and readily scalable approach for the synthesis of all-carbon quaternary allylic amino acid derivatives in excellent yields and good enantioselectivities. (Chemical Equation Presented).

Bispalladacycle-catalyzed Michael addition of in situ formed azlactones to enones

Weber, Manuel,Jautze, Sascha,Frey, Wolfgang,Peters, René

supporting information, p. 14792 - 14804 (2013/01/15)

The development and further evolution of the first catalytic asymmetric conjugate additions of azlactones as activated amino acid derivatives to enones is described. Whereas the first-generation approach started from isolated azlactones, in the second-generation approach the azlactones could be generated in situ starting from racemic N-benzoylated amino acids. The third evolution stage could make use of racemic unprotected α-amino acids to directly form highly enantioenriched and diastereomerically pure masked quaternary amino acid products bearing an additional tertiary stereocenter. The step-economic transformations were accomplished by cooperative activation by using a robust planar chiral bis-Pd catalyst, a Br?nsted acid (HOAc or BzOH; Ac=acetyl, Bz=benzoyl), and a Br?nsted base (NaOAc). In particular the second- and third-generation approaches provide a rapid and divergent access to biologically interesting unnatural quaternary amino acid derivatives from inexpensive bulk chemicals. In that way highly enantioenriched acyclic α-amino acids, α-alkyl proline, and α-alkyl pyroglutamic acid derivatives could be prepared in diastereomerically pure form. In addition, a unique way is presented to prepare diastereomerically pure bicyclic dipeptides in just two steps from unprotected tertiary α-amino acids. Flourishing step economy: The evolution of the catalytic asymmetric addition of azlactones to enones is described. The first-generation approach started from isolated azlactones. In the second-generation approach azlactones could be generated in situ from racemic N-benzoylated amino acids. The third evolution stage could directly use racemic unprotected α-amino acids to form a large number of highly enantioenriched quaternary amino acids derivatives (see figure). Copyright

PYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

-

Page/Page column 112, (2010/04/28)

The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein R1, Formula Ia, R4, R5, Formula Ib, R3, R3a, W, D, R2a, R2b and R2c are defined herein. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression, anxiety or intestinal inflammation, by administration of a therapeutically effective dose of a compound according to Formula I.

1-Azadienes in Heterocyclic Synthesis. Reaction of 1-N-Alkyl-1-azapenta-1,3-dienes with Mesoionic Oxazolones

Sain, B.,Sandhu, J. S.

, p. 1007 - 1010 (2007/10/02)

1-N-Alkyl-1-azapenta-1,3-dienes 2 smoothly reacted with various mesoionic oxazolones 1 to afford 3,4-dihydro-2-pyridones 3 in excellent yields and there is no evidence for the formation of any products arising from the cycloaddition on the carbon-carbon double bond or on the azomethine function.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 108462-95-9